EPICEPT GMBH
EPICEPT GMBH
Industry:
Pharmaceutical
Address:
Mรผnchen, Bayern, Germany
Country:
Germany
Status:
Active
More informations about "EpiCept GmbH"
EpiCept GmbH - Crunchbase Company Profile & Funding
Sub-Organization of . EpiCept Corporation . ... EpiCept GmbH is a specialty pharmaceutical company. Lists Featuring This Company. Edit Lists Featuring This Company Section. โฆSee details»
About Us - Epicept
EpiCept is focused on the development and commercialization of pharmaceutical products for the treatment of pain and cancer. The Companyโs pain portfolio includes AmiKetโข, a prescription โฆSee details»
EpiCept Corporation - Crunchbase Company Profile
EpiCept Corporation headquarters are located in Englewood Cliffs, New Jersey, with a subsidiary company, EpiCept GmbH in Munich Germany. This โฆSee details»
Immune Pharmaceuticals Completes Merger with EpiCept โฆ
Aug 26, 2013 Through its merger with EpiCept Corporation in 2013, Immune expanded its oncology pipeline with additional clinical-stage product candidates. Immune is headquartered โฆSee details»
Company register - Unternehmensregister
Immune Pharmaceuticals and EpiCept Corporation Agree to
Nov 8, 2012 Merger Details The terms of the merger agreement provide for EpiCept to issue shares of its common stock to Immune shareholders in exchange for all of the outstanding โฆSee details»
Products & Pipeline - Epicept
EpiCept Corporation, 777 Old Saw Mill River Road, Tarrytown, NY 10591 Tel: 914-606-3500 ...See details»
EpiCept Corp. (EpiCept Corp.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่่ฅ โฆ
EpiCept has been granted 10 years of market exclusivity in the EU for the treatment, which has orphan drug status. EpiCept chief executive Jack Talley noted that Ceplene is now the first โฆSee details»
EpiCept Corp: Governance, Verwaltungsrat, Geschäftsführung und ...
Erfahren Sie die Zusammensetzung des Verwaltungsrats von EpiCept Corp (Börse Other OTC), die Geschlechterparität sowie die Altersverteilung der Insider.See details»
Organization | EpiCept Corporation
EpiCept Corporation Report issue. For profit Phase 1 Phase 2 Phase 4. Founded: Englewood Cliffs NJ United States ... Organization Overview. First Clinical Trial. 2006 NCT00423410. First โฆSee details»
Company EpiCept Corp Other OTC - MarketScreener.com
EpiCept Corp: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Other OTC: | Other OTCSee details»
EpiCept Common Stock Definition - Law Insider
Define EpiCept Common Stock. shall have the meaning set forth in Section 1.5(a).See details»
EpiCept Corporation Receives FDA Permission to Initiate AmiKetโข โฆ
Dec 23, 2011 EpiCept Corporation: Robert W. Cook, 914-606-3500 [email protected] or Media: Feinstein Kean Healthcare Greg Kelley, 617-577-8110 [email protected] or Investors: LHA Kim โฆSee details»
EpiCept Transfers Ceplene Responsibilities in European Union and โฆ
Jun 19, 2012 EpiCept Transfers Ceplene Responsibilities in European Union and Sells ... ... Site searchSee details»
Company Search - German Trade Registry Smart Portal
Certificate of Good Standing. Certificate of Good Standing โ detailed certified report describing the results of the performed due diligence of a company/legal entity via the compliance โฆSee details»
EPICEPT GMBH - GERMANIA Medicamente-Online
EPICEPT GMBH - GERMANIA Medicamente-Online . Contul meu. intra in cont. Nu ai cont? Click aici. Favorite. Trebuie sa fiti logat pentru a vedea produsele favorite. Inregistrare Cosul meu. โฆSee details»
Series B - EpiCept Corporation - 2000-01-01 - Crunchbase
Jan 1, 2000 EpiCept Corporation raised $4600000 on 2000-01-01 in Series B. Start Free Trial . Chrome ExtensionSee details»
EpiCept and GNI Form Partnership to Develop Liver Disease Drug โฆ
Company in Japan and China, and EpiCept Inc., a U.S.-based biotech company, announced today that they have reached agreement for GNI to develop a new therapeutic drug, EP1013, in Asia, Australia, and New Zealand, for liver diseases induced by viral hepatitis. EpiCept will retain the rights in the rest of the world.See details»
Epicept Corp. v. Canada (Minister of Health), 2011 FCA 209
Jun 22, 2011 Epicept Corporation (appellant) and Canada's Research-based Pharmaceutical Companies (intervener) and The Minister of Health (respondent) and Canadian Generic โฆSee details»
A phase II, double-blind, randomized, placebo-controlled non ...
A phase II, double-blind, randomized, placebo-controlled non-inferiority trial of EpiCept NP-1 topical cream (2% ketamine / 4% amitriptyline) vs. oral gabapentin in postherpetic neuralgia โฆSee details»